GROWTH-CURVES OF STAPHYLOCOCCUS-AUREUS, CANDIDA-ALBICANS, AND MORAXELLA-OSLOENSIS IN PROPOFOL AND OTHER MEDIA

被引:45
作者
TESSLER, M
DASCAL, A
GIOSEFFINI, S
MILLER, M
MENDELSON, J
机构
[1] SIR MORTIMER B DAVIS JEWISH HOSP,DEPT MED,MONTREAL H3T 1E2,QUEBEC,CANADA
[2] MCGILL UNIV,MONTREAL H3A 2T5,QUEBEC,CANADA
来源
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 1992年 / 39卷 / 05期
关键词
ANESTHETICS; INTRAVENOUS; PROPOFOL; BACTERIA; GROWTH RATES;
D O I
10.1007/BF03008718
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Propofol, 2,6 diisopropylphenol, in an emulsion formulation (Diprivan), has been associated with postsurgical infections caused by Staphylococcus aureus, Moraxella osloensis and Candida albicans. These organisms were individually inoculated into each of the following media: (1) the emulsion preparation of propofol, (2) Intralipid 10%, (3) pure 2,6 diisopropylphenol, and (4) trypticase soy broth (TSB). The organisms were incubated and subcultured hourly for eight hours at room temperature. Propofol supported the growth of all three organisms, but for S. aureus and M. osloenis, the growth rate was slower in propofol than in TSB (P < 0.05). There was no difference between the growth rate of any organism in propofol than in Intralipid 10%. The authors conclude that propofol, in the emulsion formulation, supports bacterial growth and, therefore, must be prepared for administration in an aseptic manner. Also, by administering propofol soon after preparation, the risk of introduction of a significant inoculum to the patient will be reduced.
引用
收藏
页码:509 / 511
页数:3
相关论文
共 12 条
[1]   MICROBIAL-GROWTH COMPARISONS OF 5 COMMERCIAL PARENTERAL LIPID EMULSIONS [J].
CROCKER, KS ;
NOGA, R ;
FILIBECK, DJ ;
KREY, SH ;
MARKOVIC, M ;
STEFFEE, WP .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1984, 8 (04) :391-395
[2]  
De Sommer M R, 1990, Acta Anaesthesiol Belg, V41, P133
[3]   PROPOFOL - CAN A SINGLE AMPULE BE USED FOR MULTIPLE PATIENTS [J].
DOWNS, GJ ;
HALEY, PR ;
PARENT, JB .
ANESTHESIOLOGY, 1991, 74 (06) :1156-1156
[4]  
DOZE VA, 1986, ANESTH ANALG, V65, P1189
[5]  
GOODALE DB, 1991, ANESTHESIOLOGY, V74, P1156, DOI 10.1097/00000542-199106000-00031
[6]   CONTAMINATION OF SYRINGES [J].
KEMPEN, PM .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1989, 36 (06) :730-730
[7]  
KLEINBAUM DG, 1988, APPLIED REGRESSION A, P91
[8]   RECOVERY AND MORBIDITY AFTER DAYCASE ANESTHESIA - A COMPARISON OF PROPOFOL WITH THIOPENTONE ENFLURANE WITH AND WITHOUT ALFENTANIL [J].
MILLAR, JM ;
JEWKES, CF .
ANAESTHESIA, 1988, 43 (09) :738-743
[9]   A COMPARISON OF PROPOFOL AND METHOHEXITONE AS INDUCTION-AGENTS FOR DAY CASE ISOFLURANE ANESTHESIA [J].
OTOOLE, DP ;
MILLIGAN, KR ;
HOWE, JP ;
MCCOLLUM, JSC ;
DUNDEE, JW .
ANAESTHESIA, 1987, 42 (04) :373-376
[10]   COMPARISON OF PROPOFOL INDUCTION WITH THIOPENTONE OR METHOHEXITONE IN SHORT OUTPATIENT GENERAL-ANESTHESIA [J].
RAEDER, JC ;
MISVAER, G .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1988, 32 (08) :607-613